Cargando…

Impact of differing glucose‐lowering regimens on the pattern of association between glucose control and survival

AIMS: To characterize survival in relation to achieved glycated haemoglobin (HbA1c) level within alternative glucose‐lowering regimens with differing risks of hypoglycaemia. METHODS: Data were extracted from the UK Clinical Practice Research Datalink and the corresponding Hospital Episode Statistics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Currie, Craig J., Holden, Sarah E., Jenkins‐Jones, Sara, Morgan, Christopher Ll, Voss, Bernd, Rajpathak, Swapnil N., Alemayehu, Berhanu, Peters, John R., Engel, Samuel S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888185/ https://www.ncbi.nlm.nih.gov/pubmed/29119713 http://dx.doi.org/10.1111/dom.13155

Ejemplares similares

Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study
por: Morgan, Christopher Ll., et al.
Publicado: (2018)

The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010)
por: Holden, Sarah E, et al.
Publicado: (2013)

Progression of glucose‐lowering diabetes therapy in TECOS
por: Bethel, M. Angelyn, et al.
Publicado: (2018)

Outcomes Associated with Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK Primary Care Observational Study
por: Morgan, Christopher Ll., et al.
Publicado: (2019)

Use of the Estimated Glucose Disposal Rate as a Measure of Insulin Resistance in an Urban Multiethnic Population With Type 1 Diabetes
por: Epstein, Eric J., et al.
Publicado: (2013)

Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival
por: Currie, Craig J., et al.
Publicado: (2012)

Severity of hypoglycaemia and health‐related quality of life, work productivity and healthcare costs in patients with type 2 diabetes in Europe
por: Pawaskar, Manjiri, et al.
Publicado: (2018)

Impact of dipeptidyl peptidase-4 inhibitors on glucose-dependent insulinotropic polypeptide in type 2 diabetes mellitus: a systematic review and meta-analysis
por: Chai, Shangyu, et al.
Publicado: (2023)

Retrospective Cohort Analysis of the Reduced Burden of Hypoglycemia Associated with Dipeptidyl Peptidase-4 Inhibitor Use in Patients with Type 2 Diabetes Mellitus
por: Tang, Yuexin, et al.
Publicado: (2018)

Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin
por: Holden, Sarah E, et al.
Publicado: (2011)

Glucose-Lowering Medications and Post-Dementia Survival in Patients with Diabetes and Dementia
por: Secnik, Juraj, et al.
Publicado: (2022)

Impact of glucose dosing regimens on modeling of glucose tolerance and β‐cell function by intravenous glucose tolerance test in diet‐induced obese mice
por: Omar, Bilal A., et al.
Publicado: (2014)

Association between Insulin Monotherapy versus Insulin plus Metformin and the Risk of All-Cause Mortality and Other Serious Outcomes: A Retrospective Cohort Study
por: Holden, Sarah E., et al.
Publicado: (2016)

Neuropathy, Retinopathy, and Glucose-Lowering Treatments
por: Bloomgarden, Zachary T.
Publicado: (2010)

Pharmacogenetics of novel glucose-lowering drugs
por: Rathmann, Wolfgang, et al.
Publicado: (2021)

Cinnamon extract lowers glucose, insulin and cholesterol in people with elevated serum glucose
por: Anderson, Richard A., et al.
Publicado: (2015)

Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
por: Horakova, Olga, et al.
Publicado: (2019)

Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation
por: Moonira, Tabassum, et al.
Publicado: (2020)

Skin- and Plasmaautofluorescence in hemodialysis with glucose-free or glucose-containing dialysate
por: Ramsauer, Bernd, et al.
Publicado: (2017)

Effects of glucose-lowering agents on cardiorespiratory fitness
por: Hamasaki, Hidetaka
Publicado: (2018)

Effects of glucose-lowering agents on ischemic stroke
por: Avgerinos, Konstantinos, et al.
Publicado: (2017)

Role of Glucose-Lowering Medications in Erectile Dysfunction
por: Cignarelli, Angelo, et al.
Publicado: (2021)

Use of Glucose-Lowering Agents in Diabetes and CKD
por: Alicic, Radica Z., et al.
Publicado: (2022)

Induction of remission in diabetes by lowering blood glucose
por: Weir, Gordon C., et al.
Publicado: (2023)

Elevated Fasting Plasma Glucose before Liver Transplantation is Associated with Lower Post-Transplant Survival
por: Katsura, Emi, et al.
Publicado: (2016)

Sodium-Glucose Cotransporter 2 Inhibitors: Possible Anti-Atherosclerotic Effects Beyond Glucose Lowering
por: Yanai, Hidekatsu, et al.
Publicado: (2016)

Factors associated with the glucose‐lowering efficacy of sitagliptin in Japanese patients with type 2 diabetes mellitus: Pooled analysis of Japanese clinical trials
por: Tajima, Naoko, et al.
Publicado: (2019)

Adaptive survival mechanism to glucose restrictions
por: Djouder, Nabil
Publicado: (2016)

Mining treatment patterns of glucose-lowering medications for type 2 diabetes in the Netherlands
por: van den Heuvel, Jan Maurik, et al.
Publicado: (2020)

Impaired glucose tolerance and indeterminate glycemia in cystic fibrosis
por: Kasim, Nader, et al.
Publicado: (2021)

Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes
por: Currie, Craig J., et al.
Publicado: (2013)

Inhibition of upper small intestinal mTOR lowers plasma glucose levels by inhibiting glucose production
por: Waise, T. M. Zaved, et al.
Publicado: (2019)

Influence of Supervised Disease Understanding and Diabetes Self-Management on Adherence to Oral Glucose-Lowering Treatment in Patients with Type 2 Diabetes
por: Doupis, John, et al.
Publicado: (2019)

The Effect of Lowering the Threshold for Diagnosis of Impaired Fasting Glucose
por: Kim, So Hun, et al.
Publicado: (2008)

PPARγ Agonist Beyond Glucose Lowering Effect
por: Sugawara, Akira, et al.
Publicado: (2011)

Lower fasting blood glucose in neurofibromatosis type 1
por: Martins, Aline Stangherlin, et al.
Publicado: (2015)

The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs
por: Kalra, Sanjay, et al.
Publicado: (2016)

Diabetes, bone and glucose-lowering agents: basic biology
por: Lecka-Czernik, Beata
Publicado: (2017)

The Effects of Glucose-Lowering Therapies on Diabetic Kidney Disease
por: Agrawal, V., et al.
Publicado: (2015)

Glucose Lowering Effect of Basil Leaves in Diabetic Rats
por: Widjaja, Sry Suryani, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ar7qerlqspla5tfvcvpnjc0tjo